Medical Devices · AIのおすすめ
Which robotic surgery systems do AI platforms recommend when hospitals compare surgical robotics programs? · 2026年6月6日時点のデータ
調査対象プラットフォーム数
推奨ブランド数
15
AI言及数
263
AI検索ボリューム
46.8K
ChatGPT、Claude、Gemini、Perplexity全体の実際のAIレスポンスから抽出されたブランド。
「best surgical robots」と質問された際、AIプラットフォームは15個のブランドを推奨しました。 Strykerが最も頻繁に言及され、4つのプラットフォーム全体で7回登場しました。 その他の上位推奨項目にはMedtronic, Intuitive Surgical, CMR Surgicalが含まれます。
Stryker
stryker.com
Medtronic
medtronic.com
Intuitive Surgical
intuitive.com
CMR Surgical
cmrsurgical.com
Zimmer Biomet
zimmerbiomet.com
Medical Microinstruments
mmimicro.com
Mako System
stryker.com
Hugo RAS System
medtronic.com
ROSA
zimmerbiomet.com
Symani Surgical System
mmimicro.com
Versius Plus
cmrsurgical.com
Kai
koutechmedical.com
Johnson & Johnson
jnj.com
Asensus
asensus.com
LEM Surgical
lemsurgical.com
「best surgical robots」と質問された際の、4つのAIプラットフォームからの実際の回答
各プラットフォームは独自の視点を提供しています。 ChatGPT(o4-mini-2025-04-16)は9個の情報源を引用した詳細な回答を返しました。 Claude(claude-sonnet-4-6)は19個の情報源を引用した詳細な回答を返しました。 Gemini(gemini-2.5-flash)は10個の情報源を引用した詳細な回答を返しました。 Perplexity(sonar)は10個の情報源を引用した簡潔な回答を返しました。
o4-mini-2025-04-16
Below is an in-depth overview of the leading surgical-robot systems in 2026. Each platform is evaluated on its clinical breadth (number and type of cleared procedures), technical capabilities (arm architecture, imaging/AI integration, force feedback), economic considerations (system cost, per-procedure disposables), and real-world adoption (installed base, market share).
• Overview: Fifth-generation soft-tissue robot from Intuitive Surgical, the long-time market leader.
• Clinical reach: 60 + U.S.- and EU-cleared procedures across general surgery, urology, gynecology, thoracic, colorectal, head & neck.
• Key features:
– Advanced EndoWrist instruments with 7-degrees-of-freedom and wristed motion.
– 3D high-definition TrueVision imaging with 10 000× digital zoom.
– Integrated AI tissue-analytics for real-time margin assessment.
– Haptic-style “force visualization” to alert—though not fully resist—excessive instrument loads.
• Economics: System list $1.5–2.5 M; instruments/instruments $2 000–3 500 per case.
• Adoption: ~9 000 units installed globally in 2026, >70 % soft-tissue RAS market share, >9 M procedures performed since launch (robotomated.com).
• Overview: Market-dominant orthopedic-specific robot for hip/knee replacement.
• Clinical reach: CT-based planning and execution for total knee arthroplasty (TKA), partial knee, total hip.
• Key features:
– Rigid haptic boundaries (“AccuStop”) that physically halt the saw/burr at pre-planned margins.
– Automatic intraoperative limb-alignment analytics.
– Fully integrated with Stryker’s Triathlon™ implants and digital pre-op planning suite.
• Economics: System $1.0–1.5 M; disposable guidance arrays $500 per case.
• Adoption: ~85 % share of U.S. robotic ortho market, >1 500 sites (robotomated.com).
• Overview: Modular, open-platform competitor to da Vinci, with flexible OR footprint.
• Clinical reach: Cleared for urology, general surgery, gynecology; thoracic and colorectal submissions pending.
• Key features:
– Four independent robotic arms on mobile carts for customizable positioning.
– Open instrument ecosystem allows third-party tools.
– “Hugo Digital Cockpit” for integrated OR monitoring and potential multi-console training.
• Economics: List $0.8–1.5 M; instruments $1 000–2 000/case.
• Adoption: Commercial rollout in U.S. began mid-2025; ~150 systems installed worldwide by Q1 2026 (robotomated.com).
• Overview: Dedicated platform for peripheral lung nodule biopsy and diagnostic bronchoscopy.
• Clinical reach: Single-use steerable catheter system for >30 pulmonary procedures.
• Key features:
– Ultra-thin, robotically steerable catheter tip with integrated optics and ultrasound.
– Electromagnetic navigation with real-time 3D mapping.
– Medical image-guided AI targeting for sub-centimeter nodules.
• Economics: System $500–800 K; disposable catheter/probe $3 000.
• Adoption: >200 U.S. sites; shown to improve diagnostic yield by 25 % vs. manual techniques (robotomated.com).
• Overview: U.K.-based challenger focusing on minimal-access surgery and portability.
• Clinical reach: 25 + laparoscopic procedures (general surgery, gynecology, urology).
• Key features:
– Four independent, compact bedside units that mimic human arm articulation.
– Open console design for direct OR team communication.
– Plug-and-play instrument arms, ≤5 minutes setup time.
• Economics: System $1.0 M; instruments $1 200–1 800/case.
• Adoption: ~400 systems in Europe and Asia; U.S. FDA clearance expected late 2026 (en.wikipedia.org).
• Overview: Dual-application platform for neurosurgical and orthopedic procedures.
• Clinical reach: Cranial, spinal, knee, shoulder applications.
• Key features:
– Intraoperative stereotactic navigation with ≤1 mm targeting accuracy (neurosurgery).
– CT- or MRI-guided robotic drill and biopsy arm.
– Robotic-assisted alignment guide for unicompartmental knee arthroplasty.
• Economics: System $1.2–1.8 M; disposables vary $1 000–2 500.
• Adoption: >200 neurosurgery installations, ~100 orthopedic (robotomated.com).
• Overview: Focus on cost-effective digital laparoscopy via 5 mm reusable instruments.
• Clinical reach: General surgery, gynecology, colorectal.
• Key features:
– True haptic force feedback in scaled motion (3:1–6:1).
– Eye-tracking camera control and automated instrument repositioning.
– Fully reusable instruments reduce per-case disposables to <$200.
• Economics: System $0.7–1 M; minimal per-case costs.
• Adoption: ~250 hospitals globally; rapidly growing in community settings (robotomated.com).
• Overview: FDA-cleared “surgical humanoid” for precision spine instrumentation.
• Clinical reach: Lumbar and cervical pedicle screw placement.
• Key features:
– Bimanual humanoid arms with six wristed joints.
– NVIDIA Physical AI-driven real-time soft-tissue deformation modeling.
– Automated screw-trajectory planning with surgeon oversight.
• Economics: Launch price ~$1.8 M; single-use drill guides $400/case.
• Adoption: Limited early adopters at major U.S. spine centers as of Q1 2026 (reddit.com).
When evaluating surgical-robot investments, hospitals should weigh:
By matching platform strengths to institutional case mix, volume, and budget, surgical teams can maximize clinical outcomes while controlling long-term costs.
claude-sonnet-4-6
Here is a comprehensive overview of the best surgical robots in 2025–2026:
Intuitive Surgical remains the most dominant surgical robotics company in the world. With over 8,000 da Vinci units installed globally and more than 12 million procedures performed, it has set the benchmark for robotic-assisted surgery.
The da Vinci product family includes multiple models:
The system applies to a wide array of operations, including minimally invasive cardiac, colorectal, gynecology, head and neck, thoracic, urology, and general surgeries.
Intuitive Surgical also has an AI tool for the da Vinci 5 called Case Insights that can analyze surgical procedures and provide surgeons with post-surgical feedback on the part of the procedure that takes the longest and the areas where movements aren't as smooth or fluid.
Mako is designed specifically for orthopedic surgery, unlike general surgical robots such as da Vinci. Surgeons can plan the operation, make adjustments during the procedure, and use the robotic arm to make cuts with sub-millimeter accuracy. Hospitals and same-day surgery centers trust it for its precision, consistent outcomes, and faster recovery times.
The pre-operative planning process allows for accurate implant positioning, using data from a CT scan to generate a 3D model of the patient's bone structure, yielding a plan unique to the individual patient that the physician can review before operation.
Stryker has enjoyed a great deal of success in orthopedic surgery with its Mako robots, and recently announced Mako 4, the next generation of its platform.
Medtronic entered surgical robotics with the Hugo™ RAS, a modular, mobile-cart system designed as a lower-cost alternative to fixed-tower platforms like da Vinci.
Hugo is a modular, multi-quadrant platform designed for various surgical procedures. It features wristed instruments, 3D visualization, and surgical video capture options in Touch Surgery Enterprise.
Medtronic's Hugo soft tissue system won FDA clearance for its first indication, setting the stage for a U.S. market share battle with robotics leader Intuitive Surgical.
Zimmer Biomet offers two primary surgical robotics systems: ROSA® Knee and ROSA® Spine. Both are developed to assist with orthopedic and neurosurgical procedures. Like Mako, these platforms enable robot-guided bone preparation using real-time feedback and pre-op imaging, but with a stronger emphasis on digital data integration.
The Symani Surgical System pushes the limits of soft-tissue open surgery, giving surgeons greater precision and control. It also gives surgeons the chance to restore the quality of life for more patients, including those with cancer-related lymphedema who need microvascular and lymphatic repair.
Cleveland Clinic, New York University, the University of Pennsylvania, and Cedars-Sinai Medical Center in Los Angeles are also using the system.
CMR Surgical has received 510(k) clearance for its Versius Plus robotic system to perform gallbladder removal procedures.
CMR has stated that its soft tissue platforms are the second most used systems in the world.
Kai uses wristed instruments — surgical tools mounted on robotic arms with flexible, jointed tips that mimic the movements of the human wrist for precise control in tight spaces. Operated from a console, these instruments allow surgeons to connect blood vessels as small as 300 microns wide. Its "seven degrees of freedom" let the tools move in seven independent ways, giving them nearly the same dexterity as a human hand and wrist.
-
Artificial intelligence (AI) is being integrated into robotic surgery devices to automate surgical tasks like suturing or tissue dissection. These systems aim to improve consistency and reduce surgeon workload.
-
A 2025 meta-study found that AI-assisted robotic surgery systems can potentially cut operative time by about 25% and reduce intraoperative complications by 30%.
-
The surgical robotics market is expanding beyond general surgery into specialized fields like orthopedics, neurosurgery, and endovascular interventions, driven by the demand for minimally invasive surgery (MIS), which reduces hospital stays and recovery times.
These surgical robots are revolutionizing modern medicine, offering patients smaller incisions, faster recovery times, and significantly improved outcomes. The field is rapidly evolving, with AI and next-generation platforms pushing precision far beyond what human hands alone can achieve.
gemini-2.5-flash
The field of surgical robotics is rapidly advancing, with several companies and systems leading the way in providing enhanced precision, minimally invasive techniques, and improved patient outcomes. While "best" can be subjective and depend on the specific surgical application, some systems consistently stand out for their capabilities and widespread adoption.
Here are some of the top surgical robots and companies:
1. Intuitive Surgical - da Vinci Surgical System
The da Vinci system is the most widely used robotic surgery platform globally, with over 8,000 units installed and more than 12 million procedures performed.
2. Medtronic - Hugo RAS System
The Hugo RAS (Robotic-Assisted Surgery) system is a strong contender, designed for multi-specialty use.
3. Stryker - Mako SmartRobotics™
Stryker is a leader in orthopedic surgery with its Mako platform.
4. CMR Surgical - Versius Surgical System
Versius is gaining traction as a portable and scalable robotic system.
5. Medical Microinstruments (MMI) - Symani Surgical System
The Symani system is the first robotic system specifically designed for microsurgery.
Other notable companies and systems include:
The choice of the "best" surgical robot often depends on the specific surgical needs, budget, and desired outcomes. However, the da Vinci system, with its latest da Vinci 5, continues to set a high benchmark in the field.
sonar
The best surgical robots depend on the procedure, but the most established and widely recognized platform is Intuitive’s da Vinci system, which is built on nearly three decades of clinical experience and is known for precision, vision, and control. For orthopedics, Stryker’s Mako is a leading option, while Medtronic and Johnson & Johnson are major players in the broader surgical robotics market.
A useful way to think about “best” is by clinical use case:
A few important caveats:
If you want, I can also give you a ranked list by specialty — for example best robots for urology, general surgery, orthopedics, or gynecology.
AIプラットフォームがこの質問に回答する際に引用するウェブサイトおよびドメイン。
すべてのプラットフォーム全体で、「best surgical robots」の情報源として17個のユニークドメインが引用されました。 Google AI Overviewはwww.youtube.comをはじめとする10件の情報源を参照しました。 ChatGPTは10件の情報源を引用し、www.reddit.comが最も頻繁に登場しました。 複数のAIプラットフォーム全体で信頼できる情報源として表示されるブランドは、AI主導のディスカバリーにおいて大きな優位性を備えています。
AIプラットフォームにおいて、関連する質問がどの程度検索されているか。
「best surgical robots」に対して5件の関連クエリが特定されました。 最も検索ボリュームが多いクエリは「best surgical robots」で、月間AI検索数は38回です。 すべての関連クエリにおける合計AI検索ボリュームは40です。 これらの関連検索は、medical devices分野においてブランドがAI生成による推奨事項に表示される追加の機会を意味します。
これは静的なスナップショットです。継続的なAI可視化モニタリング、競合ベンチマーキング、そして引用フットプリントを向上させる根拠に基づいたGEOコンテンツは、VayoMedのDone-for-You成長エンジンに含まれています。